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Secondary leptomeningeal dissemination of oligodendroglioma is very rare. We report the case of a 38-year-old Caucasian male
who presented with acute hydrocephalus. 8 months before, the patient had undergone craniotomy for right frontal anaplastic
oligodendroglioma, WHO grade III. By that time, there was no evidence of tumor dissemination. MRI now ruled out local
tumor progression but revealed meningeal contrast enhancement along the medulla, the myelon, and the cauda equina. Repeated
lumbar puncture revealed increased cerebro-spinal ﬂuid (CSF) pressure and protein content. Malignant cells were not detectable.
Surgical treatment consisted in (1) placement of an ommaya reservoir for daily CSF puncture, (2) Spinal dural biopsy conﬁrming
leptomeningeal oligodendroglioma metastasis, and (3) ventriculo-peritoneal shunt placement after CSF protein has decreased to
1500–2000mg/l.
Copyright © 2009 Andreas M. Stark et al. This is an open access article distributed under the Creative Commons Attribution




clinical course is particularly characterized by seizures. The
preferred location is in the cortex and white matter of the
cerebral hemispheres, most often located in the frontal lobe.
Nevertheless, oligodendroglioma has also been reported in
the cerebellum, brain stem, or spinal cord [1].




The tumor usually presents as a solid mass. However,
several cases of primary diﬀuse leptomeningeal oligoden-
drogliomatosis have been reported [2–5]. Most of these
patients were children or young adults [2, 4, 5]. In contrast,
secondary leptomeningeal dissemination from a solid tumor
mass is extremely rare [6].
We report the case of a 38-year-old male with secondary
cranial and spinal leptomeningeal tumor dissemination 8
months after surgical resection of an anaplastic oligo-
dendroglioma WHO grade III of the right frontal lobe.
The treatment was intended to prove the dissemination
histologically and to treat hydrocephalus appropriately.
2. Case Presentation
2.1. History and Examination. A 38-year-old patient pre-
sentedtoourdepartmentwiththe4-dayhistoryofheadache,
nausea, vomiting, and visual disturbance. He also com-
plained about progressive back pain radiating into both
legs. The patient had undergone subtotal tumor resection
for anaplastic oligodendroglioma (WHO grade III, MIB1
proliferation index 50%) of the right frontal lobe 8 months
before. At the time of initial surgery, there were no signs
of leptomeningeal tumor involvement or hydrocephalus
(Figures 1(a) to 1(d)). Surgery was followed by radiotherapy.
Cranial computed tomography (CCT) on admission
now revealed marked ventricular enlargement. Magnetic
resonance imaging (MRI) exhibited enlargement of the2 Case Reports in Medicine
(a) (b) (c)
(d) (e) (f)
Figure 1: (a)–(d) Cranial MRI at initial presentation before surgical treatment of right frontal anaplastic oligodendroglioma. (a): axial T1-
weighted contrast-enhanced MRI, (b) axial ﬂuid-attenuated inversion recovery (FLAIR), and (c) sagittal T1-weighted contrast-enhanced
MRI revealed a hyperintense lesion on the right cingulate gyrus with slight local mass eﬀect (arrows). (d): T2-weighted axial MRI showing
regular ventricular size. (e)-(f): MRI at second presentation 8 months after initial surgery. (e): sagittal T1-weighted contrast-enhanced
MRI showing meningeal enhancement in the craniocervical junction (arrows). (f): Axial T2-weighted MRI showed marked ventricular
enlargement.
lateral ventricles and the third ventricle with periventricular
high intensity signal on T2WI suggesting transependymal
absorptionortumorspreading(Figures1(e)and1(f)).There
were no signs of local tumor recurrence. Meningeal contrast
enhancement was detected around the medulla (arrow head
inFigure 1(f)).MRIofthewholespineshowedenhancement
along the leptomeninges and partially nodular enhancement
of the dura. The cauda equina ﬁbers appeared thickened
and clotted together (arrow head in Figures 2(a) and 2(b)).
Lumbar puncture repeatedly revealed yellow and muddy
CSF with an increased opening pressure of about 50cm
H2O. CSF examination showed marked elevation of pro-
tein (15972mg/l), slightly elevated cell count (16/µL), and
normal glucose and lactate. Cytological CSF examination
showed monocytes and lymphocytes but was free of tumor
cells.
2.2. Surgical Treatment. An Ommaya reservoir was placed
for daily CSF puncture. Herein, CSF protein content was
decreasing to an amount of 1500–2000mg/l. Yet there were
no tumor cells detectable in consecutive cytological CSF
examinations. MRI had shown a marked dural contrast
enhancement on the L 2/3 level. So, we decided to biopsy the
dura and the nerve ﬁbers on this level. Intraoperatively the
nerve ﬁbers were covered with a grayish layer while the dura
appeared normal. Biopsies were taken from the nerve ﬁbers
and the dura.
Histological examination conﬁrmed tumor cell inﬁltra-
tion of the dura and nerve ﬁbers by the known anaplastic
oligodendroglioma (Figure 3). Remarkably, intraoperatively
drawn CSF was again free of tumor cells. Daily puncture of
the Ommaya reservoir became insuﬃcient for CSF drainage.
So, a ventricular-peritoneal shunt (medium pressure) was
inserted after the CSF protein content decreased to an
amount of approximately 1500mg/l.
2.3. Postoperative Follow-Up. Postoperatively, PCV chemo-
therapy (procarbazine, lomustine, vincristine) was planned
but refused by the patient. Four months after presentation
with hydrocephalus, the patient was clinically stable without
any signs of shunt malfunction or tumor progression.
3. Discussion
Primary and Secondary Dissemination of Oligodendroglioma.
Oligodendroglioma mostly arises as a solid mass but can
also appear as a diﬀuse leptomeningeal lesion (oligoden-






Figure 2: (a) Sagittal and (b) transversal T1-weighted contrast-enhanced magnetic resonance imaging (MRI) of the spine demonstrates
meningeal enhancement along the lumbar spinal canal (arrows). Additional enhancement was seen in the cauda equine nerve roots. The
biopsy was performed on level L 2/3 (long arrow in (a), level of (b)).
(a) (b) (c)
Figure 3: (a) Histopathological image of the primary tumor showing moderate cellularity and a rounded, clear cytoplasm. Histological
examination of the dura and the nerve roots revealed inﬁltration by cells of the anaplastic astrocytoma: (b) Hematoxylin-Eosin staining,
magniﬁcation 250-fold. (c) Elastica-van-Gieson staining showed tumor cells within dural collagen ﬁbers, magniﬁcation 500-fold.
PDLG). PDLG is assigned a fatal diagnosis and is frequently
associated with hydrocephalus [1–5, 7]. It is assumed that
PDLG derives from heterotopic nests of neuroglial tissue in
the meninges [8].
In contrast, secondary spinal leptomeningeal dissemina-
tion from oligodendroglioma is very rare. In 1977, Arseni
et al. reported two cases of secondary spinal involvement in
patients with oligodendroglioma from the pre-CT era. The
WHO grade is not available. In one case of an 8-year-old
boy with pubertas praecox, cachexia, and visual disturbance
ventriculography revealed a tumor of the third ventricle.
Subtotal tumor resection was followed by radiotherapy. 2
years later, the patient presented with a spinal subdural
t u m o rf r o mC 1t oC 5w h i c hw a sa g a i nt r e a t e ds u r g i c a l l y .
The second patient was a 39-year-old male with the his-
tory of left-sided Jackson seizures. Angiography revealed a
right temporal lesion which was excised and diagnosed as
oligodendroglioma. Radiotherapy was applied. 15 months
later, the patient presented with spinal pain and progressive
paraparesis. Laminectomy from T1 to T3 revealed a spinal
subdural oligodendroglioma [6].
3.1. Surgical Treatment of Tumor-Induced Hydrocephalus.
Treatment of hydrocephalus in patients with central-nervous
system tumors is often a challenge due to the following facts:
(A) it remains unclear if raised CSF protein content may
cause shunt dysfunction. Most surgeons believe not only
that high CSF protein content aﬀects valve function but
also that it aﬀects viscosity [9]. According to manufacturers‘
information, modern shunt valves should tolerate protein
content up to 2000–3000mg/dl. However, there is no
threshold the surgeon could rely on. (B) shunt insertion
might lead to dissemination of tumor cells into the blood
stream or peritoneum. This incidence might be controlled
by systemic chemotherapy. (C) tumor dissemination might
be diﬃcult to prove [7]. If the CSF is cytologically tumor
free,biopsyofgadolinium-enhancingstructuresidentiﬁedin4 Case Reports in Medicine
MRI might be necessary. Notably, hydrocephalus in patients
who underwent surgical intervention might have other
causes: (A) Subarachnoid bleeding, either tumor-induced
[10] or related to surgery and (B) bacterial meningitis.
In our patient, we had to consider all these facts in order
to apply adequate treatment. The raised CSF protein content
wasbroughtbacktoacceptablevaluesbydailypunctureofan
ommaya reservoir. Since cytological examination of repeated
lumbar and reservoir puncture was negative for tumor cells,
spinal dural biopsy was performed in order to establish
the diagnosis. Finally, ventriculo-peritoneal shunting was
performed for persistent hydrocephalus in combination
with PCV chemotherapy (which was ﬁnally refused by the
patient).
4. Conclusion
Secondary cranial and spinal dissemination in patients with
anaplastic oligodendroglioma is extremely rare. It should be
kept in mind when these patients report with signs of hydro-
cephalus or back pain. The diagnostic method of choice is
MRI before and after contrast administration. Cytological
CSF examination might be negative. As a consequence, sur-
gical biopsy might be necessary. Treatment of hydrocephalus
can include emergency lumbar puncture (after CT or MRI),
ommaya reservoir placement, and shunt insertion. The latter
should be accompanied by chemotherapy in order to prevent
metastasis to other organs.
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